Stay updated on RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma
Sign up to get notified when there's something new on the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page.

Latest updates to the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page
- Check2 days agoChange DetectedNo additions or deletions to core page content were detected; the study details and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check30 days agoChange Detected- Updated version from v3.1.0 to v3.2.0. - Added a government-operating-status notice about funding lapse and the NIH Clinical Center openness, directing users to cc.nih.gov and opm.gov for status updates.SummaryDifference3%

- Check37 days agoChange DetectedUpdated contact details and versioning: added multiple new emails/phone numbers for various contacts and bumped the revision from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release. The 'Back to Top' link was removed as a minor UI change.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as various new medical terms related to proteins and antibodies. Notably, previous references to specific diseases and genetic resources have been removed.SummaryDifference3%

Stay in the know with updates to RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma
Enter your email address, and we'll notify you when there's something new on the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page.